XiMed Group PLC

XiMed is an unique Pharmaceutical Healthcare Micro Group that acquires and develops NCEs for out-licensing. XiMed Group Plc, founded in July 1998 is an integrated pharmaceutical micro group which functions as the holding company for the subsidiaries, Phytogenics, Reductogen and BioClinical Services (BioClin). These companies are active in the nutraceutical, pharmaceutical, and bioanalytical fields, respectively, and have expertise ranging from new drug acquisition through pharmaceutical and nutritional development to contract analysis.

Activity:

- Licensing & Business Development

Product / Technology type(s) covered:

- Bio
- NCE (new chemical entities)
- OTC (over the counter drugs)
- Pharmaceuticals / Therapeutics
- Nutritionals / Vitamins

Therapeutic targets:

Markets Covered

a. HeadQuarter:

b. Continent(s) active:

c. Countries active:

Corporate data:

Number of Employees:

Turnover:

Amount:	Year:	Currency:

Year founded: